Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma

Robert J. Motzer, Konstantin Penkov, John Haanen, Brian Rini, Laurence Albiges, Matthew T. Campbell, Balaji Venugopal, Christian Kollmannsberger, Sylvie Negrier, Motohide Uemura, Jae L. Lee, Aleksandr Vasiliev, Wilson H. Miller, Howard Gurney, Manuela Schmidinger, James Larkin, Michael B. Atkins, Jens Bedke, Boris Alekseev, Jing WangMariangela Mariani, Paul B. Robbins, Aleksander Chudnovsky, Camilla Fowst, Subramanian Hariharan, Bo Huang, Alessandra Di Pietro, Toni K. Choueiri

Research output: Contribution to journal › Article › peer-review

1698 Scopus citations

Fingerprint

Dive into the research topics of 'Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences